{"DataElement":{"publicId":"3444619","version":"1","preferredName":"Uterine Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Distant Metastasis M Stage","preferredDefinition":"Extent of the distant metastasis for the uterine carcinoma based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3444513v1.0:3444580v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3444513","version":"1","preferredName":"Corpus Uteri Neoplasm Clinical M Stage","preferredDefinition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"3444507v1.0:2207806v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3444507","version":"1","preferredName":"Corpus Uteri Neoplasm","preferredDefinition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12316:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Corpus Uteri","conceptCode":"C12316","definition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CE75-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CECB-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3444580","version":"1","preferredName":"Corpus Uteri Carcinoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical M Stage","preferredDefinition":"A clinical finding about one or more characteristics of uterine corpus carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3444580v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M0","valueDescription":"Uterine Corpus Carcinoma cM0 TNM Finding v7","ValueMeaning":{"publicId":"3444582","version":"1","preferredName":"Uterine Corpus Carcinoma cM0 TNM Finding v7","longName":"3444582","preferredDefinition":"Uterine corpus carcinoma with no distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma cM0 TNM Finding v7","conceptCode":"C89577","definition":"Uterine corpus carcinoma with no distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D29B-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D2B4-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"M1","valueDescription":"Uterine Corpus Carcinoma cM1 TNM Finding v7","ValueMeaning":{"publicId":"3444584","version":"1","preferredName":"Uterine Corpus Carcinoma cM1 TNM Finding v7","longName":"3444584","preferredDefinition":"Uterine corpus carcinoma with distant metastasis (includes metastasis to inguinal lymph nodes intraperitoneal disease, or lung, liver, or bone.  It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma cM1 TNM Finding v7","conceptCode":"C89578","definition":"Uterine corpus carcinoma with distant metastasis (includes metastasis to inguinal lymph nodes intraperitoneal disease, or lung, liver, or bone.  It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D2C1-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D2DA-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3444579","version":"1","preferredName":"Uterine Corpus Carcinoma Clinical Distant Metastasis TNM Finding v7 American Joint Committee on Cancer Stage","preferredDefinition":"A clinical finding about one or more characteristics of uterine corpus carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89576:C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma Clinical Distant Metastasis TNM Finding v7","conceptCode":"C89576","definition":"A clinical finding about one or more characteristics of uterine corpus carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D26F-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D280-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3444894","version":"1","longName":"Corpus Uteri Carcinoma","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777530","version":"1","longName":"Uterine","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Clinical M Stage","type":"Preferred Question Text","description":"Clinical M Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BEE854C9-9E78-50CA-E040-BB89AD4341D5","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}